PMID- 22732512 OWN - NLM STAT- MEDLINE DCOM- 20130402 LR - 20220410 IS - 1600-0641 (Electronic) IS - 0168-8278 (Linking) VI - 57 IP - 4 DP - 2012 Oct TI - The metabolic regulator PGC-1alpha links hepatitis C virus infection to hepatic insulin resistance. PG - 867-73 LID - 10.1016/j.jhep.2012.06.021 [doi] AB - BACKGROUND & AIMS: Chronic hepatitis C virus (HCV) infection is strongly associated with insulin resistance and diabetes mellitus. Peroxisome proliferator-activated receptor-gamma co-activator 1alpha (PGC-1alpha) is a transcriptional co-activator involved in the initiation of gluconeogenesis in the liver. Increased hepatic expression of PGC-1alpha has been implicated in insulin resistance. We investigated whether modulation of PGC-1alpha levels following HCV infection underlies HCV-associated hepatic insulin resistance. METHODS: HCV genomes were expressed in hepatoma cells followed by analysis of PGC-1alpha and gluconeogenesis levels. RESULTS: PGC-1alpha was robustly induced in HCV infected cells. PGC-1alpha induction was accompanied by an elevated expression of the gluconeogenic gene glucose-6 phosphatase (G6Pase) and increased glucose production. The induction of gluconeogenesis is HCV dependent, since interferon treatment abolishes PGC-1alpha and G6Pase elevation and decreases glucose output. Moreover, PGC-1alpha knockdown resulted in a significant reduction of G6Pase levels in HCV full length replicon cells, emphasizing the central role of PGC-1alpha in the exaggerated gluconeogenic response observed in HCV patients. Treatment of HCV replicon cells with the antioxidant N-acetylcysteine resulted in reduction of PGC-1alpha levels, suggesting that HCV-induced oxidative stress promoted PGC-1alpha upregulation. Finally, both PGC-1alpha and G6Pase RNA levels were significantly elevated in liver samples of HCV infected patients, highlighting the clinical relevance of these results. CONCLUSIONS: PGC-1alpha is robustly induced following HCV infection, resulting in an upregulated gluconeogenic response, thereby linking HCV infection to hepatic insulin resistance. Our results suggest that PGC-1alpha is a potential molecular target for the treatment of HCV-associated insulin resistance. CI - Copyright (c) 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. FAU - Shlomai, Amir AU - Shlomai A AD - The Research Center for Digestive Tract and Liver Diseases, Tel-Aviv Sourasky Medical Center and The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. FAU - Rechtman, Maya Mouler AU - Rechtman MM FAU - Burdelova, Ela Olga AU - Burdelova EO FAU - Zilberberg, Alona AU - Zilberberg A FAU - Hoffman, Sarit AU - Hoffman S FAU - Solar, Irit AU - Solar I FAU - Fishman, Sigal AU - Fishman S FAU - Halpern, Zamir AU - Halpern Z FAU - Sklan, Ella H AU - Sklan EH LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120623 PL - Netherlands TA - J Hepatol JT - Journal of hepatology JID - 8503886 RN - 0 (Heat-Shock Proteins) RN - 0 (Interferon-alpha) RN - 0 (PPARGC1A protein, human) RN - 0 (Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha) RN - 0 (RNA, Messenger) RN - 0 (RNA, Viral) RN - 0 (Transcription Factors) RN - EC 3.1.3.9 (Glucose-6-Phosphatase) RN - WYQ7N0BPYC (Acetylcysteine) SB - IM MH - Acetylcysteine/pharmacology MH - Cell Line, Tumor MH - Electroporation MH - Gene Knockdown Techniques MH - Genotype MH - Gluconeogenesis/genetics MH - Glucose-6-Phosphatase/genetics/metabolism MH - Heat-Shock Proteins/*genetics/*metabolism MH - Hepacivirus/genetics/*metabolism/physiology MH - Hepatitis C, Chronic/*metabolism MH - Humans MH - *Insulin Resistance MH - Interferon-alpha/pharmacology MH - Liver/cytology/metabolism/*virology MH - Oxidative Stress MH - Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha MH - RNA, Messenger/metabolism MH - RNA, Viral/metabolism MH - Replicon MH - Transcription Factors/*genetics/*metabolism MH - Transcriptional Activation/drug effects MH - Up-Regulation MH - Virus Replication EDAT- 2012/06/27 06:00 MHDA- 2013/04/03 06:00 CRDT- 2012/06/27 06:00 PHST- 2011/12/17 00:00 [received] PHST- 2012/05/19 00:00 [revised] PHST- 2012/06/14 00:00 [accepted] PHST- 2012/06/27 06:00 [entrez] PHST- 2012/06/27 06:00 [pubmed] PHST- 2013/04/03 06:00 [medline] AID - S0168-8278(12)00447-3 [pii] AID - 10.1016/j.jhep.2012.06.021 [doi] PST - ppublish SO - J Hepatol. 2012 Oct;57(4):867-73. doi: 10.1016/j.jhep.2012.06.021. Epub 2012 Jun 23.